NC 300 Pill - purple capsule/oblong, 20mm
Pill with imprint NC 300 is Purple, Capsule/Oblong and has been identified as Carbamazepine Extended Release 300 mg. It is supplied by Nostrum Laboratories, Inc.
Carbamazepine is used in the treatment of Trigeminal Neuralgia; Schizoaffective Disorder; Bipolar Disorder; Epilepsy and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NC 300


Carbamazepine Extended Release
- Imprint
- NC 300
- Strength
- 300 mg
- Color
- Purple
- Size
- 20.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Nostrum Laboratories, Inc.
- National Drug Code (NDC)
- 29033-0004
- Inactive Ingredients
-
ethylcellulose (20 mPa.s),
silicon dioxide,
sodium lauryl sulfate,
microcrystalline cellulose,
oleic acid,
medium-chain triglycerides,
hypromellose 2910 (6 mPa.s),
polyethylene glycol,
D&C Red No. 28,
FD&C Blue No. 1,
gelatin,
ferrosoferric oxide,
titanium dioxide,
D&C Yellow No. 10,
aluminum oxide,
FD&C Blue No. 2,
FD&C Red No. 40,
shellac
Note: Inactive ingredients may vary.
Related images for "NC 300"
More about carbamazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (342)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Carbamazepine drug information
- Carbamazepine (Intravenous) (Advanced Reading)
- Carbamazepine (Oral) (Advanced Reading)
- Carbamazepine Chewable Tablets
- Carbamazepine Extended-Release Capsules (Carbatrol)
Other brands
Tegretol, Carbatrol, Tegretol XR, Equetro, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.